Newsletter
Every new paper in this field, in your inbox.
Income changes do not significantly impact the rate of patients undergoing surgical resection for early-stage pancreatic cancer. A study including 23,968 patients from 173 counties across 11 states showcases an overall resection rate of 45.1%, which increased from 42.8% to 47.4% between the early and…
Two-step vascular exclusion and in situ hypothermic portal perfusion during liver resection proves safe and effective for patients with advanced hepatic hydatidosis. With minimal complications and reduced anhepatic time, this technique allows for successful surgical treatment, resulting in good postoperative recovery and shortened hospital stays.…
Robotic surgery in hepatobiliary oncology, using the da Vinci Xi system, resulted in favorable patient outcomes with a low conversion rate, no postoperative mortality, and high 5-year overall survival and disease-free survival rates. Patient selection was crucial for success. The study highlights the technical superiority…
Researchers found that 21.7% of patients developed main pancreatic duct (MPD) dilatation 1 year after pancreatoduodenectomy (PD), which was significantly associated with impaired exocrine function. Endocrine function, nutritional status, and fatty liver development were not affected. A serum total protein level ≥7.3 g/dL was identified…
Serum amylase ≥120 IU/L on postoperative day one is a robust predictor of postoperative pancreatic fistula after pancreaticoduodenectomy. In a study of 132 patients, high serum amylase level, soft pancreatic texture, and high-risk pathology were independent risk factors for fistula development. For patients with soft…
Postoperative pancreatic fistulas are a significant issue following partial pancreatectomy. A meta-analysis of 18 randomized clinical trials involving 2326 patients revealed that both artificial and autologous coverage techniques reduced the incidence of postoperative pancreatic fistulas by 29%. Specifically, autologous coverage was even more effective for…
Targeted therapy plus immunotherapy combined with hepatic arterial infusion chemotherapy (FOLFOX) showed a 60.4% objective response rate and 83.0% one-year overall survival in patients with unresectable hepatocellular carcinoma. The regimen demonstrated a 34.0% surgical conversion rate, with manageable adverse events. These findings suggest a promising…
Augmented reality navigation combined with indocyanine green fluorescence imaging significantly improves safety and precision in laparoscopic left hemihepatectomy for hepatolithiasis. The new method successfully aided in guiding hilar vessel dissection and identifying liver resection boundaries, with no major complications reported. This combined approach offers enhanced…
Integration of machine learning into prognostic modeling for distal cholangiocarcinoma yielded a robust predictive model for disease-free survival after pancreaticoduodenectomy. Significant predictors of recurrence included lnr15, neural invasion, n stage, surgical radicality, and differentiation grade. The model demonstrated strong discriminatory capacity with internal and external…
Pancreatic cancer's radiomorphological appearance on MRI correlates with tumor budding, a marker of poor prognosis. Intermediate to high spiculation on MRI was seen in 64% of tumors, with over 90% showing tumor buds. A positive correlation existed between MRI spiculation grade and histopathological tumor bud…
